649 related articles for article (PubMed ID: 30655087)
1. The Microbiome and Genitourinary Cancer: A Collaborative Review.
Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
[TBL] [Abstract][Full Text] [Related]
2. Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
Maisch P; Koll F; Bolenz C; Chun FK; Gschwend JE; Schmid SC
Urol Oncol; 2023 May; 41(5):219-232. PubMed ID: 36372634
[TBL] [Abstract][Full Text] [Related]
3. The Microbiome and Prostate Cancer Risk.
Wheeler KM; Liss MA
Curr Urol Rep; 2019 Sep; 20(10):66. PubMed ID: 31493090
[TBL] [Abstract][Full Text] [Related]
4. Urinary microbiome profile in men with genitourinary malignancies.
Ahn HK; Kim K; Park J; Kim KH
Investig Clin Urol; 2022 Sep; 63(5):569-576. PubMed ID: 36068003
[TBL] [Abstract][Full Text] [Related]
5. Bibliography. Current world literature. Genitourinary systems.
Curr Opin Oncol; 2000 May; 12(3):B104-33. PubMed ID: 10841204
[No Abstract] [Full Text] [Related]
6. The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer.
Kustrimovic N; Bilato G; Mortara L; Baci D
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38339010
[TBL] [Abstract][Full Text] [Related]
7. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
8. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.
Shrestha E; White JR; Yu SH; Kulac I; Ertunc O; De Marzo AM; Yegnasubramanian S; Mangold LA; Partin AW; Sfanos KS
J Urol; 2018 Jan; 199(1):161-171. PubMed ID: 28797714
[TBL] [Abstract][Full Text] [Related]
9. Using Imaging to Predict Treatment Response in Genitourinary Malignancies.
Lebastchi AH; Watson MJ; Russell CM; George AK; Weizer AZ; Turkbey B
Eur Urol Focus; 2018 Dec; 4(6):804-817. PubMed ID: 28918178
[TBL] [Abstract][Full Text] [Related]
10. Urobiome in Gender-Related Diversities of Bladder Cancer.
Bilski K; Dobruch J; Kozikowski M; Skrzypczyk MA; Oszczudłowski M; Ostrowski J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599810
[TBL] [Abstract][Full Text] [Related]
11. The microbiome of the urinary tract--a role beyond infection.
Whiteside SA; Razvi H; Dave S; Reid G; Burton JP
Nat Rev Urol; 2015 Feb; 12(2):81-90. PubMed ID: 25600098
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and prostate cancer.
Rizzo A; Santoni M; Mollica V; Fiorentino M; Brandi G; Massari F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1058-1065. PubMed ID: 34536504
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
Surolia I; Gulley J; Madan RA
Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
[TBL] [Abstract][Full Text] [Related]
14. Gut and urinary microbiota: the causes and potential treatment measures of renal cell carcinoma.
Yang JW; Wan S; Li KP; Chen SY; Yang L
Front Immunol; 2023; 14():1188520. PubMed ID: 37441065
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
Sanford EJ; Drago JR; Rohner TJ; Kessler GF; Sheehan L; Lipton A
J Urol; 1975 Feb; 113(2):218-21. PubMed ID: 1113419
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary malignancy.
Hudes GR; Ozols RF; Giantonio B
Cancer Chemother Biol Response Modif; 1994; 15():531-54. PubMed ID: 7779598
[No Abstract] [Full Text] [Related]
17. Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review.
Russo AE; Memon A; Ahmed S
Clin Genitourin Cancer; 2024 Apr; 22(2):434-444. PubMed ID: 38220540
[TBL] [Abstract][Full Text] [Related]
18. The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
Bajic P; Wolfe AJ; Gupta GN
Urology; 2019 Apr; 126():10-15. PubMed ID: 30615894
[TBL] [Abstract][Full Text] [Related]
19. The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers.
O'Brian D; Prunty M; Hill A; Shoag J
Front Immunol; 2021; 12():721989. PubMed ID: 34512646
[TBL] [Abstract][Full Text] [Related]
20. Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients.
Pederzoli F; Ferrarese R; Amato V; Locatelli I; Alchera E; Lucianò R; Nebuloni M; Briganti A; Gallina A; Colombo R; Necchi A; Clementi M; Montorsi F; Mancini N; Salonia A; Alfano M
Eur Urol Oncol; 2020 Dec; 3(6):784-788. PubMed ID: 32345542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
